Search results
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 3 hours ago"Novavax seeks FDA approval for updated Covid-19 vaccine" was originally created and published by...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoIt's important to note, Sanofi isn't helping Novavax commercialize in 2024. Nuvaxovid is available...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 3 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 5 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 4 days agoVaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax each ...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 7 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun via Yahoo News· 2 days agoVaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were prepared to make JN.1-targeted vaccines available in ...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 3 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 6 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
CNBC Daily Open: Apple upgrades Siri with AI
CNBC· 6 days agoThe S&P 500 and the Nasdaq Composite inched to record highs ahead of the Federal Reserve's interest rate decision. Shares of Apple fell 1.9% after the iPhone maker delivered its long-awaited ...